Brind.

Zimmer Biomet announces advancements in its product portfolio, including the ROSA Robotic Platform, Persona OsseoTi, and Oxford Partial Cementless Knee.

2 reports, 1 independent Updated Aug 28
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Zimmer Biomet announces advancements in its product portfolio, including the ROSA Robotic Platform, Persona OsseoTi, and Oxford Partial Cementless Knee.

Who's involved

What this event is mainly about
Zimmer Biomet Holdings

How it developed

Newest first. Tap a step to see who reported it.
  1. Zimmer Biomet advances its product lines through portfolio combination and expansion.1 source
  2. FDA clearance achieved for revision knee implant component; portfolio traction drives business growth.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksShould You Add Zimmer Biomet Stock to Your Portfolio Now? Zimmer Biomet ZBH is advancing the expansion of its ROSA Robotic Platform alongside its Persona OsseoTi and Oxford Partial Cementless Knee an
  • ZacksZimmer Biomet to Report Q2 Earnings: Here's What to Expect Zimmer Biomet Holdings, Inc. ZBH is scheduled to report second-quarter 2025 results on Aug. 7, before market open. In the last reported quar